Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
CERS Cerus Corporation daily Stock Chart
CERS [NASD]
Cerus Corporation
Healthcare | Biotechnology | USA
financial highlights | statements
Index- P/E- EPS (ttm)-0.49 Insider Own2.00% Shs Outstand138.28M Perf Week-3.65%
Market Cap730.12M Forward P/E- EPS next Y-0.39 Insider Trans-4.12% Shs Float137.54M Perf Month-7.21%
Income-66.80M PEG- EPS next Q-0.12 Inst Own72.80% Short Float3.97% Perf Quarter1.73%
Sales84.00M P/S8.69 EPS this Y21.90% Inst Trans8.43% Short Ratio5.35 Perf Half Y-17.88%
Book/sh0.47 P/B11.23 EPS next Y22.00% ROA-39.50% Target Price8.50 Perf Year-25.11%
Cash/sh0.70 P/C7.59 EPS next 5Y- ROE-85.70% 52W Range4.49 - 7.81 Perf YTD4.14%
Dividend- P/FCF- EPS past 5Y7.40% ROI-48.30% 52W High-32.39% Beta1.64
Dividend %- Quick Ratio2.30 Sales past 5Y13.90% Gross Margin60.60% 52W Low17.73% ATR0.22
Employees240 Current Ratio2.70 Sales Q/Q15.40% Oper. Margin-73.70% RSI (14)47.93 Volatility3.50% 4.47%
OptionableYes Debt/Eq0.67 EPS Q/Q-25.60% Profit Margin-79.50% Rel Volume0.98 Prev Close5.40
ShortableYes LT Debt/Eq0.60 EarningsAug 01 AMC Payout- Avg Volume1.02M Price5.28
Recom2.00 SMA20-3.07% SMA50-0.98% SMA200-6.54% Volume1,000,114 Change-2.22%
Aug-23-19Resumed Stephens Overweight
Jan-05-18Resumed Cantor Fitzgerald Overweight
Dec-08-17Resumed BTIG Research Neutral
Jul-07-16Resumed Cantor Fitzgerald Buy $9
Dec-17-15Downgrade Wedbush Outperform → Neutral
May-02-14Reiterated MLV & Co Buy $8.50 → $6
Apr-24-13Reiterated Cantor Fitzgerald Buy $5.50 → $6
Mar-15-13Reiterated MLV & Co Buy $7.50 → $8.50
Apr-17-12Initiated Cantor Fitzgerald Buy $5.50
Feb-29-12Upgrade Robert W. Baird Neutral → Outperform $3 → $6
Nov-10-11Reiterated MLV & Co Buy $4 → $5
Jun-03-11Initiated Wedbush Outperform $4
Mar-04-11Downgrade Robert W. Baird Outperform → Neutral $4 → $3
Mar-09-10Upgrade Robert W. Baird Neutral → Outperform $3 → $5
Aug-26-09Upgrade Avondale Mkt Perform → Mkt Outperform $2 → $5
Jul-28-09Downgrade Robert W. Baird Outperform → Neutral $3
May-04-09Downgrade JMP Securities Mkt Perform → Mkt Underperform
Feb-27-09Downgrade Avondale Mkt Outperform → Mkt Perform
May-02-08Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jan-29-08Initiated JMP Securities Mkt Outperform
Aug-14-19 09:44AM  What Kind Of Shareholder Appears On The Cerus Corporation's (NASDAQ:CERS) Shareholder Register? Simply Wall St.
Aug-05-19 01:14PM  Edited Transcript of CERS earnings conference call or presentation 1-Aug-19 8:30pm GMT Thomson Reuters StreetEvents -5.81%
Aug-01-19 09:24PM  Cerus Corporation (CERS) Q2 2019 Earnings Call Transcript Motley Fool
06:35PM  Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:01PM  Cerus Corporation Announces Record Second Quarter 2019 Results Business Wire
Jul-25-19 10:34AM  Analysts Estimate Cerus (CERS) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-22-19 08:30AM  Cerus Corporation to Release Second Quarter 2019 Results on August 1, 2019 Business Wire
Jul-08-19 11:54AM  Cerus Corporation (NASDAQ:CERS): Time For A Financial Health Check Simply Wall St.
Jul-05-19 04:39PM  Heres What Hedge Funds Think About Cerus Corporation (CERS) Insider Monkey
Jun-24-19 06:00PM  Cerus Corporation Announces Presentations Highlighting INTERCEPT Blood System at the 29th Regional Congress of the ISBT Business Wire
Jun-13-19 08:01AM  Edited Transcript of CERS earnings conference call or presentation 7-May-19 8:30pm GMT Thomson Reuters StreetEvents
Jun-04-19 02:16PM  How Cerus Corporation (NASDAQ:CERS) Can Impact Your Portfolio Volatility Simply Wall St.
Jun-03-19 08:30AM  Cerus Corporation Announces New Corporate Brand and Global Headquarters Business Wire
May-14-19 08:44AM  Cerus INTERCEPT Blood System Provides Alternative to Year-Round Babesia Testing in Latest FDA Guidance Document Business Wire
May-07-19 08:23PM  Cerus Corporation (CERS) Q1 2019 Earnings Call Transcript Motley Fool
07:25PM  Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates Zacks
06:18PM  Cerus: 1Q Earnings Snapshot Associated Press
04:05PM  Cerus Corporation Announces Record First Quarter 2019 Results Business Wire
10:53AM  Heres What Hedge Funds Think About Cerus Corporation (CERS) Insider Monkey
Apr-30-19 10:32AM  Analysts Estimate Cerus (CERS) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-25-19 08:30AM  Cerus Corporation to Release First Quarter 2019 Results on May 7, 2019 Business Wire
Apr-24-19 11:48AM  Cerus Corporation (NASDAQ:CERS) Insiders Have Been Selling Simply Wall St.
Apr-01-19 04:05PM  Cerus Corporation Strengthens Balance Sheet with an Expandable Debt Facility of up to $90 Million Business Wire
Mar-05-19 04:15PM  Cerus Corporation Announces Appointment of Jami Nachtsheim to Board of Directors Business Wire
Feb-28-19 10:31PM  Edited Transcript of CERS earnings conference call or presentation 26-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Feb-26-19 11:02PM  Cerus Corporation (CERS) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:02PM  Cerus Corporation Announces Record Fourth Quarter and Full Year 2018 Results Business Wire
Feb-22-19 08:30AM  Cerus to Participate In Upcoming Investor Conferences Business Wire
Feb-21-19 11:20AM  How Much Of Cerus Corporation (NASDAQ:CERS) Do Institutions Own? Simply Wall St.
Feb-14-19 07:20AM  Consolidated Research: 2019 Summary Expectations for Varonis, Dolby Laboratories, Alder BioPharmaceuticals, Retail Properties of America, Cerus, and Motorcar Parts of America Fundamental Analysis, Key Performance Indications GlobeNewswire
Feb-13-19 08:30AM  Cerus to Release Fourth Quarter and Full Year 2018 Results on February 26, 2019 Business Wire
Jan-16-19 11:00AM  How Should Investors React To Cerus Corporations (NASDAQ:CERS) CEO Pay? Simply Wall St.
Jan-07-19 08:30AM  Cerus Announces Preliminary Fourth Quarter and Full Year 2018 Product Revenue Business Wire
Jan-04-19 08:30AM  William Moore Appointed as Cerus Corporations Senior Vice President of Manufacturing Operations and Supply Chain Business Wire
Dec-19-18 08:30AM  Cerus Announces First Patient Enrolled in the Phase 3 ReCePI Study Business Wire
Dec-18-18 08:30AM  Cerus Completes CE Mark Submission for INTERCEPT Red Blood Cells Business Wire
02:14AM  Do Hedge Funds Love Cerus Corporation (CERS)? Insider Monkey
Dec-17-18 10:39AM  What Investors Should Know About Cerus Corporations (NASDAQ:CERS) Financial Strength Simply Wall St.
Dec-10-18 08:30AM  American Red Cross Receives Biologics License Application Approval For INTERCEPT Platelets Business Wire
Dec-04-18 05:00PM  Cerus Supports FDAs Continuing Efforts to Enhance the Safety of the U.S. Platelet Supply Business Wire
Nov-15-18 10:48AM  Does Cerus Corporation (NASDAQ:CERS) Have A Particularly Volatile Share Price? Simply Wall St.
Nov-12-18 07:20AM  Report: Developing Opportunities within Lexicon Pharmaceuticals, Cray, RCI Hospitality, Sanmina, Diamond Offshore Drilling, and Cerus Future Expectations, Projections Moving into 2018 GlobeNewswire -8.03%
Nov-09-18 08:30AM  Cerus to Present at the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum Business Wire
Nov-08-18 07:19PM  Edited Transcript of CERS earnings conference call or presentation 1-Nov-18 8:15pm GMT Thomson Reuters StreetEvents
Nov-02-18 08:30AM  Cerus to Present at the 2018 Stephens NY Investment Conference Business Wire -5.91%
Nov-01-18 05:25PM  Cerus: 3Q Earnings Snapshot Associated Press
04:01PM  Cerus Corporation Reports Third Quarter 2018 Results Business Wire
Oct-31-18 08:30AM  Cerus Receives FDA Breakthrough Device Designation for Pathogen-Reduced Cryoprecipitate Business Wire +6.52%
Oct-23-18 08:30AM  Cerus to Release Third Quarter 2018 Results on November 1, 2018 Business Wire
Oct-18-18 08:10AM  Detailed Research: Economic Perspectives on Cerus, AdvanSix, Spark Therapeutics, Imperva, Central Garden & Pet, and Francesca's What Drives Growth in Today's Competitive Landscape GlobeNewswire
Oct-16-18 03:01PM  Here's Why Cerus Corporation Stock Popped Today Motley Fool +15.44%
08:30AM  Cerus to Provide Update to Development Programs and Outline Growth Strategy at 2018 Institutional Investor Meeting Business Wire
Oct-12-18 08:30AM  Cerus Announces Schedule of Presentations at the 2018 AABB Annual Meeting Business Wire
Oct-11-18 08:30AM  Dr. Laurence Corash Recognized With the Prestigious Dale A. Smith Memorial Award Business Wire
Oct-10-18 11:28AM  Cerus Corporations (NASDAQ:CERS) Most Important Factor To Consider Simply Wall St. -5.03%
Oct-09-18 04:05PM  Cerus Appoints Eric Bjerkholt to Board of Directors Business Wire
Oct-02-18 08:30AM  Cerus to Host Institutional Investor Meeting Business Wire
Sep-26-18 08:30AM  Cerus to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference Business Wire
Sep-06-18 04:15PM  Cerus Appoints Timothy L. Moore to Board of Directors Business Wire
Sep-04-18 11:11AM  Cerus Corporation (NASDAQ:CERS): Is Now The Time To Bet On Healthcare? Simply Wall St.
Aug-28-18 08:15AM  New Research Coverage Highlights Evertec, Cerus, REV Group, U.S. Silica, The Manitowoc, and World Fuel Services Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Aug-13-18 11:34PM  Edited Transcript of CERS earnings conference call or presentation 2-Aug-18 8:15pm GMT Thomson Reuters StreetEvents
Aug-06-18 07:30AM  Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates (Revised) Zacks
Aug-02-18 06:20PM  Cerus (CERS) Reports Q2 Loss, Misses Revenue Estimates Zacks
05:13PM  Cerus: 2Q Earnings Snapshot Associated Press
04:03PM  Cerus Corporation Reports Second Quarter 2018 Results Business Wire
02:15PM  Cerus Corporation to Host Earnings Call ACCESSWIRE
Jul-31-18 07:15AM  Free Stock Performance Review on Biogen and Three Additional Biotech Stocks ACCESSWIRE
Jul-30-18 07:26AM  Zacks.com featured highlights include: OFG, Northern Oil, Sunrun, Cerus and Veracyte Zacks
Jul-27-18 08:41AM  5 Breakout Stocks Offering Stellar Returns Zacks
Jul-19-18 08:30AM  Cerus to Release Second Quarter 2018 Results on August 2, 2018 Business Wire
Jul-10-18 08:30AM  New Navy Policy Implements Full Adoption of Pathogen-Reduced Apheresis Platelets Collected at U.S. Navy Blood Donor Centers Business Wire
Jun-28-18 08:25AM  Report: Developing Opportunities within Torchmark, Cerus, American Equity Investment Life Holding, Southern Copper, F5 Networks, and Diebold Nixdorf Future Expectations, Projections Moving into 2018 GlobeNewswire
07:20AM  Free Technical Reports on Cerus and Three Additional Biotech Equities ACCESSWIRE
Jun-25-18 08:20AM  Cerus Corporation Sees Product Demand Double, Revises Guidance Upward ACCESSWIRE
Jun-15-18 11:30AM  Cerus Presents Results of European Phase 3 Chronic Anemia Study at the 23rd Congress of European Hematology Association Business Wire
Jun-01-18 08:30AM  Cerus Announces Presentations Highlighting INTERCEPT Blood Systems at the 35th International Congress of the International Society of Blood Transfusion Business Wire
May-18-18 07:05AM  Audentes Therapeutics and Three More Stocks Under Scanner in the Biotech Space ACCESSWIRE
May-16-18 05:15PM  Cerus Announces Additional BARDA Funding to Support Development of INTERCEPT Blood System for Red Blood Cells Business Wire
May-15-18 08:20AM  New Research Coverage Highlights Cerus, Health Insurance Innovations, Tetra Tech, Ferro, Dril-Quip, and MSC Industrial Direct Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
May-11-18 11:46PM  Edited Transcript of CERS earnings conference call or presentation 8-May-18 8:15pm GMT Thomson Reuters StreetEvents
May-09-18 01:45PM  Here's Why Cerus Corporation Stock Is Surging Today Motley Fool +14.99%
May-08-18 05:25PM  Cerus: 1Q Earnings Snapshot Associated Press
04:03PM  Cerus Corporation Reports First Quarter 2018 Results Business Wire
May-03-18 08:30AM  Cerus to Present at the Deutsche Bank 43rd Annual Health Care Conference on Wednesday May 9, 2018 Business Wire
Apr-25-18 08:30AM  Cerus to Release First Quarter 2018 Results on May 8, 2018 Business Wire
08:30AM  Cerus Announces Health Canada Approval of the INTERCEPT Blood System for Platelets Business Wire
Apr-02-18 08:30AM  Cerus RedeS Phase 3 Red Blood Cell Study Expands Into the Continental U.S. Business Wire
Mar-28-18 03:39PM  Blood transfusion company inks deal for new East Bay headquarters American City Business Journals
Mar-22-18 08:15AM  Cerus Corporation, Shares Up 39% in the Past Month, Analysts Review, INTERCEPT ACCESSWIRE
Mar-19-18 08:36AM  Cerus (CERS) Looks Good: Stock Adds 9.5% in Session Zacks
Mar-16-18 07:10AM  Wired News FDA Accepted Tymes IND Application to Begin Phase-II Clinical Study for SM-88 in Pancreatic Cancer ACCESSWIRE +9.54%
Mar-14-18 07:10PM  Is Cerus Corporations (NASDAQ:CERS) Balance Sheet A Threat To Its Future? Simply Wall St. +5.65%
Mar-13-18 07:30AM  Cerus Announces the Fourth Biologics License Application (BLA) Approval for a U.S. Blood Center Customer Business Wire
Mar-09-18 04:06PM  Edited Transcript of CERS earnings conference call or presentation 8-Mar-18 9:15pm GMT Thomson Reuters StreetEvents
Mar-08-18 04:37PM  Cerus reports 4Q loss Associated Press
04:03PM  Cerus Corporation Reports Record Fourth Quarter and Year End 2017 Results Business Wire
12:00PM  Cerus Corporation to Host Earnings Call ACCESSWIRE
Mar-07-18 08:30AM  Cerus to Present at the Cowen and Company 38th Annual Health Care Conference on March 13, 2018 Business Wire
Mar-01-18 02:47PM  Should You Be Holding Cerus Energy Group Ltd (CVE:CEA) Right Now? Simply Wall St.
Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; and INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion. It markets platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was founded in 1991 and is headquartered in Concord, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ANDERSON TIMOTHY BDirectorAug 19Option Exercise2.6219,00549,793184,472Aug 20 07:00 PM
ANDERSON TIMOTHY BDirectorAug 19Sale5.569,13150,739176,541Aug 20 07:00 PM
ANDERSON TIMOTHY BDirectorAug 16Option Exercise2.6219,00049,780177,649Aug 20 07:00 PM
ANDERSON TIMOTHY BDirectorAug 16Sale5.259,66450,736167,985Aug 20 07:00 PM
Benjamin Richard JChief Medical OfficerAug 07Sale5.0116,44482,3240Aug 09 05:12 PM
Greenman William MarinerPresident and CEOJun 04Buy4.6010,00046,000638,485Jun 04 05:09 PM
Greenman William MarinerPresident and CEOApr 22Option Exercise1.06100106628,485Apr 22 05:27 PM
Green Kevin DennisChief Financial OfficerApr 10Option Exercise2.152,7865,99082,059Apr 10 05:50 PM
Green Kevin DennisChief Financial OfficerApr 10Sale6.512,78618,13879,273Apr 10 05:50 PM
Menard ChrystalChief Legal OfficerMar 13Sale5.908,81151,98432,407Mar 13 08:46 PM
Moore CarolSVP Reg. & QualityMar 13Sale5.908,81151,98250,343Mar 13 08:47 PM
Green Kevin DennisChief Financial OfficerMar 13Sale5.902,83216,70769,418Mar 13 08:37 PM
Jayaraman Vivek KChief Commercial OfficerMar 13Sale5.905,97935,27475,163Mar 13 08:45 PM
Greenman William MarinerPresident and CEOMar 13Sale5.9037,678222,287561,277Mar 13 08:38 PM
Benjamin Richard JChief Medical OfficerMar 13Sale5.908,81151,9856,589Mar 13 08:28 PM
Benjamin Richard JChief Medical OfficerMar 12Sale6.481,0796,9921,921Mar 13 08:28 PM
Greenman William MarinerPresident and CEOMar 12Sale6.487,78150,421543,771Mar 13 08:38 PM
Green Kevin DennisChief Financial OfficerMar 12Sale6.482,07513,44664,750Mar 13 08:37 PM
Moore CarolSVP Reg. & QualityMar 12Sale6.482,07513,44645,675Mar 13 08:47 PM
Menard ChrystalChief Legal OfficerMar 12Sale6.481,97212,77927,739Mar 13 08:46 PM
Green Kevin DennisChief Financial OfficerMar 11Option Exercise2.152,7835,98367,533Mar 13 08:37 PM
Green Kevin DennisChief Financial OfficerMar 11Sale6.462,78317,97564,750Mar 13 08:37 PM
Green Kevin DennisChief Financial OfficerFeb 11Option Exercise2.152,7835,98363,608Feb 12 05:19 PM
Green Kevin DennisChief Financial OfficerFeb 11Sale5.862,78316,31360,825Feb 12 05:19 PM
Green Kevin DennisChief Financial OfficerJan 10Option Exercise2.152,7835,98363,608Jan 11 05:31 PM
Green Kevin DennisChief Financial OfficerJan 10Sale5.592,78315,56360,825Jan 11 05:31 PM
Greenman William MarinerPresident and CEODec 28Option Exercise0.79150,000118,500549,601Dec 31 04:01 PM
Green Kevin DennisChief Financial OfficerDec 10Option Exercise2.152,7835,98363,608Dec 11 05:25 PM
Green Kevin DennisChief Financial OfficerDec 10Sale5.352,78314,88960,825Dec 11 05:25 PM
Green Kevin DennisChief Financial OfficerNov 12Option Exercise2.152,7835,98363,608Nov 13 07:05 PM
Green Kevin DennisChief Financial OfficerNov 12Sale5.562,78315,47260,825Nov 13 07:05 PM
Green Kevin DennisChief Financial OfficerOct 10Option Exercise2.152,7835,98363,608Oct 11 06:47 PM
Green Kevin DennisChief Financial OfficerOct 10Sale6.092,78316,94660,825Oct 11 06:47 PM
Greenman William MarinerPresident and CEOSep 27Option Exercise4.1940,000167,600399,601Oct 01 12:00 AM
Green Kevin DennisChief Financial OfficerSep 10Option Exercise2.152,7835,98363,608Sep 10 07:46 PM
Green Kevin DennisChief Financial OfficerSep 10Sale7.242,78320,14160,825Sep 10 07:46 PM
Green Kevin DennisChief Financial OfficerAug 28Option Exercise3.0050,000150,000110,825Aug 29 07:13 PM
Benjamin Richard JChief Medical OfficerAug 28Option Exercise4.7250,000236,00050,000Aug 30 07:40 PM
Benjamin Richard JChief Medical OfficerAug 28Sale7.5250,000376,0550Aug 30 07:40 PM
Green Kevin DennisChief Financial OfficerAug 28Sale7.5050,000375,00560,825Aug 29 07:13 PM
open in yahoo | open in reuters | open in google